Lori Reilly

Guest

Vice president of policy and research for the Pharmaceutical Research and Manufacturers of America,  which represents leading research-based pharmaceutical companies in the US

Lori Reilly on KCRW

One third of all Americans will get some form of cancer during their lifetimes — and the average cost of drug treatment is $100,000 a year.

The Rising Cost of Fighting Cancer

One third of all Americans will get some form of cancer during their lifetimes — and the average cost of drug treatment is $100,000 a year.

from To the Point

Patents are about to expire on two of the world's best-selling prescription drugs.

Expiring Patents, Drug Prices and the Hazy Market for Generics

Patents are about to expire on two of the world's best-selling prescription drugs.

from To the Point

More from KCRW

It was supposed to be infrastructure week for real this time.

from Left, Right & Center

It’s a special live episode from USC Gould School of Law!

from LRC Presents: All the President's Lawyers

Tech workers at Amazon are risking their jobs to combat climate change.

from To the Point

Hollywood's triumph in the global culture wars is a serious cause for concern at a time in which conglomerates and uniformity reign, argues French scholar Violaine Roussel.

from Scheer Intelligence

Congress is investigating misconduct alleged by the Mueller report. White House lawyers are rejecting every subpoena.

from To the Point

This week, we moved a lot closer to a court challenge that could significantly reduce or eliminate constitutional protections for abortion rights.

from Left, Right & Center

Even with redactions, there’s plenty to discuss

from Left, Right & Center

Even the Wild West had gun control. Most Americans want it now--especially kids afraid of school shootings.

from To the Point